1. Schaap DP, Boogerd LSF, Konishi T, et al. Rectal cancer lateral lymph nodes: multicentre study of the impact of obturator and internal iliac nodes on oncological outcomes. Br J Surg 2021; 108: 205-13.
2.
Ozaki K, Kawai K, Nozawa H, et al. Impact of the viability assessment of lateral lymph node metastasis in rectal cancer after neoadjuvant chemoradiotherapy. Int J Colorect Dis 2022; 37: 467-73.
3.
Ogura A, Konishi T, Cunningham C, et al. Neoadjuvant (chemo)radiotherapy with total mesorectal excision only is not sufficient to prevent lateral local recurrence in enlarged nodes: results of the multicenter lateral node study of patients with low cT3/4 rectal cancer. J Clin Oncol 2019; 37: 33-43.
4.
Sakai Y, Hida K. Real-world situation of lateral lymph node dissection for rectal cancer in Japan. Dis Colon Rectum 2019; 62: e29.
5.
Manabe T, Koga Y, Kubo H, et al. Adverse effects on the postoperative urinary function after combined resection of inferior vesical artery in laparoscopic lateral pelvic lymph node dissection: retrospective analysis of consecutive 95 series. Surg Laparosc Endosc Percutan Tech 2019; 29: 493-7.
6.
Ishizaki T, Mazaki J, Enomoto M, et al. A new technique for robotic lateral pelvic lymph node dissection for advanced low rectal cancer with emphasis on en bloc resection and inferior vesical vessel preservation. Surg Endosc 2022; 36: 7789-93.
7.
Jiang Y, Zhou S, Pei W, et al. Does lateral lymph node dissection increase urogenital dysfunction in middle to lower rectal cancer? Asian J Surg 2022; 45: 1914-5.
8.
Zhang Z, Yang H, Li P, et al. The consequences of laparoscopic fascial space priority approach to lateral lymph node dissection on urinary and sexual functionality. Videosurgery Miniinv 2023; 18: 639-44.
9.
Sun Y, Zhang Z, Zhou Y, et al. Fascial space priority approach in laparoscopy: lateral pelvic lymph node dissection for advanced low rectal cancer. Tech Coloproctol 2020; 24: 335-6.
10.
Chen JN, Liu Z, Wang ZJ, et al. Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer. World J Gastroenterol 2020; 26: 2877-88.
11.
Fujita S, Mizusawa J, Kanemitsu Y, et al. Mesorectal excision with or without lateral lymph node dissection for clinical stage II/III lower rectal cancer (JCOG0212): a multicenter, randomized controlled, noninferiority trial. Ann Surg 2017; 266: 201-7.
12.
Kanemitsu Y, Komori K, Shida D, et al. Potential impact of lateral lymph node dissection (LLND) for low rectal cancer on prognoses and local control: a comparison of 2 high-volume centers in Japan that employ different policies concerning LLND. Surgery 2017; 162: 303-14.
13.
Beppu N, Jihyung S, Takenaka Y, et al. Laparoscopic lateral pelvic lymph node dissection combined with removal of the internal iliac vessels in rectal cancer: how to standardize this surgical procedure. Tech Coloproctol 2021; 25: 579-87.
14.
Ma P, Yuan Y, Yan P, et al. The efficacy and safety of lateral lymph node dissection for patients with rectal cancer: a systematic review and meta-analysis. Asian J Surg 2020; 43: 891-901.
15.
Georgiou P, Tan E, Gouvas N, et al. Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis. Lancet Oncol 2009; 10: 1053-62.
16.
Cheng H, Deng Z, Wang ZJ, et al. Lateral lymph node dissection with radical surgery versus single radical surgery for rectal cancer: a meta-analysis. Asian Pac J Cancer Prev 2011; 12: 2517-21.
17.
Akasu T, Sugihara K, Moriya Y. Male urinary and sexual functions after mesorectal excision alone or in combination with extended lateral pelvic lymph node dissection for rectal cancer. Ann Surg Oncol 2009; 16: 2779-86.
18.
Kyo K, Sameshima S, Takahashi M, et al. Impact of autonomic nerve preservation and lateral node dissection on male urogenital function after total mesorectal excision for lower rectal cancer. World J Surg 2006; 30: 1014-9.
19.
Sadakari Y, Hisano K, Sada M, et al. Long-term effects of laparoscopic lateral pelvic lymph node dissection on urinary retention in rectal cancer. Surg Endosc 2022; 36: 999-1007.
20.
Yoo BE, Kye BH, Kim HJ, et al. Early removal of the urinary catheter after total or tumor-specific mesorectal excision for rectal cancer is safe. Dis Colon Rectum 2015; 58: 686-91.
21.
Lee SY, Kang SB, Kim DW, et al. Risk factors and preventive measures for acute urinary retention after rectal cancer surgery. World J Surg 2014; 39: 275-82.
22.
Benoist S, Panis Y, Denet C, et al. Optimal duration of urinary drainage after rectal resection: a randomized controlled trial. Surgery 1999; 125: 135-41.
23.
Meillat H, Magallon C, Brun C, et al. Systematic early urinary catheter removal integrated in the full enhanced recovery after surgery (ERAS) protocol after laparoscopic mid to lower rectal cancer excision: a feasibility study. Ann Coloproctol 2021; 37: 204-11.
24.
Emile SH, Elfeki H, Shalaby M, et al. Outcome of lateral pelvic lymph node dissection with total mesorectal excision in treatment of rectal cancer: a systematic review and meta-analysis. Surgery 2021; 169: 1005-15.
25.
Ogura A, Konishi T, Beets GL, et al. Lateral nodal features on restaging magnetic resonance imaging associated with lateral local recurrence in low rectal cancer after neoadjuvant chemoradiotherapy or radiotherapy. JAMA Surg 2019; 154: e192172.
26.
Shizaki T, Katsumata K, Enomoto M, et al. Predictors of lateral pelvic lymph node metastasis in advanced low rectal cancer treated with neoadjuvant chemotherapy. Anticancer Res 2022; 42: 2113-21.
Copyright: © 2024 Fundacja Videochirurgii This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
